Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Lugol’s Solution and Other Iodide Preparations: Perspectives and Research Directions in Graves’ Disease
source: Endocrine
year: 2017
authors: Calissendorff J, Falhammar H
summary/abstract:Lugol’s solution and other preparations containing iodide have for almost a century been used as an adjuvant treatment in patients with Graves’ disease planned for thyroidectomy. Iodide has been shown to decrease thyroid hormone levels and reduce blood flow within the thyroid gland. An escape phenomenon has been feared as the iodide effect has been claimed to only be temporary. Lugol’s solution has many additional effects and is used in other settings beside the thyroid.
Still, there are questions of its mode of action, which doses should be deployed, if it should be used preoperative in all thyroidectomies or only in a few selected ones if at all, what is its use in other forms of thyrotoxicosis besides Graves’ disease, and what is the mechanism acting on the vasculature and if these effects are confined only to arterial vessels supporting the thyroid or not. This review aims to collate current available data about Lugol’s solution and other iodide preparations in the management of Graves’ disease and give some suggestions where more research is needed.
organization: Karolinska University Hospital, SwedenDOI: 10.1007/s12020-017-1461-8
read more full text
myBinderRelated Content
-
Early, Effective Control of Graves’ Disease Improves Survival, Regardless of TreatmentAn early and intensive control of hypert...
-
Patients’ Perceptions and Views of Surgery and Radioiodine Ablation in the Definitive Management of GravesR...Background: Patients' perceptions and p...
-
Radioactive Iodine Can Be First-Line for Hyperthyroidism, Says UKNew UK guidelines for the treatment of h...
-
Total Thyroidectomy (Tx) Versus Thionamides (Antithyroid Drugs) in Patients With Moderate-to-Severe Graves’ Op...Background: Graves' disease (GD) is cha...
-
Quality-of-Life Impairments Persist Six Months After Treatment of Graves’ Hyperthyroidism and Toxic Nodular Go...Background: The treatment of hyperthyro...
-
Reversible Pulmonary Hypertension and Clinical Right Heart Failure Associated With Graves’ DiseaseBackground: Heart failure is typically ...
-
Impaired Decision Making Under Risky Conditions in the Acute Phase of Graves’ ThyroitoxicosisThe patients with Graves' thyroitoxicosi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Google